Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (321-330 of 335) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|May 28, 2018
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E Schmieder, Felix Mahfoud, et al.
The Journal of Experimental Medicine|July 31, 2013
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophilsLaura Raccosta, Raffaella Fontana, Daniela Maggioni, et al.
Journal of the American College of Cardiology|January 1, 2016
Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST IITed Feldman, Saibal Kar, Sammy Elmariah, et al.
JAMA Cardiology|September 1, 2018
One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical TrialSanjiv J Shah, Ted Feldman, Mark J Ricciardi, et al.
Nature Communications|May 5, 2018
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progressionDiego Farinello, Monika Wozińska, Elisa Lenti, et al.
The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
The EMBO Journal|May 8, 2020
Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesityHirotaka Kanoh, Takahiro Nitta, Shinji Go, et al.
The New England Journal of Medicine|September 3, 2019
Complete Revascularization with Multivessel PCI for Myocardial InfarctionShamir R Mehta, David A Wood, Robert F Storey, et al.
The New England Journal of Medicine|August 13, 2016
Sharing Data from Cardiovascular Clinical Trials--A Proposal, Manesh R Patel, Paul W Armstrong, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 19, 2016
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesGlenn N Levine, Eric R Bates, John A Bittl, et al.
Pageof 34

Showing results (321-330 of 335) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|May 28, 2018
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E Schmieder, Felix Mahfoud, et al.
The Journal of Experimental Medicine|July 31, 2013
The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophilsLaura Raccosta, Raffaella Fontana, Daniela Maggioni, et al.
Journal of the American College of Cardiology|January 1, 2016
Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST IITed Feldman, Saibal Kar, Sammy Elmariah, et al.
JAMA Cardiology|September 1, 2018
One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical TrialSanjiv J Shah, Ted Feldman, Mark J Ricciardi, et al.
Nature Communications|May 5, 2018
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progressionDiego Farinello, Monika Wozińska, Elisa Lenti, et al.
The New England Journal of Medicine|November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
The EMBO Journal|May 8, 2020
Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesityHirotaka Kanoh, Takahiro Nitta, Shinji Go, et al.
The New England Journal of Medicine|September 3, 2019
Complete Revascularization with Multivessel PCI for Myocardial InfarctionShamir R Mehta, David A Wood, Robert F Storey, et al.
The New England Journal of Medicine|August 13, 2016
Sharing Data from Cardiovascular Clinical Trials--A Proposal, Manesh R Patel, Paul W Armstrong, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 19, 2016
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesGlenn N Levine, Eric R Bates, John A Bittl, et al.
Pageof 34